EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NaV1.1 contributes to the cell cycle of human mesenchymal stem cells by regulating AKT and CDK2

Mohammed Fouad Zakaria, Hiroki Kato iD, Soichiro Sonoda, Kenichi Kato, Norihisa Uehara, Yukari Kyumoto-Nakamura, Mohammed Majd Sharifa, Liting Yu, Lisha Dai, Haruyoshi Yamaza, Shunichi Kajioka, Fusanori Nishimura und 1 weitere

Journal of Cell Science · 01.10.2024 · 137 (19)

DOI: 10.1242/jcs.261732 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cell Science, online erschienen am 10.10.2024. Verfasst von Mohammed Fouad Zakaria und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Cell Biology and Oral Anatomy, Kyushu University Graduate School of Dental Science, Fukuoka 812-8582, Japan. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase 2, Mesenchymal Stem Cells, NAV1.1 Voltage-Gated Sodium Channel, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, UBE Industries Foundation, Takeda Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-excitable cells express sodium voltage-gated channel alpha subunit 1 gene and protein (known as SCN1A and NaV1.1, respectively); however, the functions of NaV1.1 are unclear. In this study, we investigated the role of SCN1A and NaV1.1 in human mesenchymal stem cells (MSCs). We found that SCN1A was expressed in MSCs, and abundant expression of NaV1.1 was observed in the endoplasmic reticulum; however, this expression was not found to be related to Na+ currents. SCN1A-silencing reduced MSC proliferation and delayed the cell cycle in the S phase. SCN1A silencing also suppressed the protein levels of CDK2 and AKT (herein referring to total AKT), despite similar mRNA expression, and inhibited AKT phosphorylation in MSCs. A cycloheximide-chase assay showed that SCN1A-silencing induced CDK2 but not AKT protein degradation in MSCs. A proteolysis inhibition assay using epoxomicin, bafilomycin A1 and NH4Cl revealed that both the ubiquitin–proteasome system and the autophagy and endo-lysosome system were irrelevant to CDK2 and AKT protein reduction in SCN1A-silenced MSCs. The AKT inhibitor LY294002 did not affect the degradation and nuclear localization of CDK2 in MSCs. Likewise, the AKT activator SC79 did not attenuate the SCN1A-silencing effects on CDK2 in MSCs. These results suggest that NaV1.1 contributes to the cell cycle of MSCs by regulating the post-translational control of AKT and CDK2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclin-Dependent Kinase 2Mesenchymal Stem CellsNAV1.1 Voltage-Gated Sodium ChannelProto-Oncogene Proteins c-aktTooth, DeciduousCell CycleUbiquitinProteasome Endopeptidase ComplexLysosomesProteolysisActive Transport, Cell NucleusHumans

Stichwörter der Autor:innen

SCN1AAKTCDK2Cell cycleMesenchymal stem cellsNaV1.1

Substanzen

CDK2 protein, humanCyclin-Dependent Kinase 2NAV1.1 Voltage-Gated Sodium ChannelProto-Oncogene Proteins c-aktSCN1A protein, humanUbiquitinProteasome Endopeptidase Complex

Autor:innen und Institutionen

  • Department of Molecular Cell Biology and Oral Anatomy, Kyushu University Graduate School of Dental Science, Fukuoka 812-8582, Japan.
  • Department of Periodontology, Faculty of Dental Science, Kyushu University, Fukuoka 812-8582, Japan.
  • Department of Nursing, Fukuoka School of Health Sciences, Fukuoka 814-0005, Japan.
  • Department of Pediatric Dentistry, Kyushu University Graduate School of Dental Science, Fukuoka 812-8582, Japan.
  • Department of Pharmacy in Fukuoka, International University of Health and Welfare, Okawa 831-8501, Japan.

ORCID-Profile: Hiroki Kato, Takayoshi Yamaza

Förderung

  • Japan Society for the Promotion of Science
  • UBE Industries Foundation
  • Takeda Science Foundation
  • The Japan Epilepsy Research Foundation
  • Japan Epilepsy Research Foundation
  • Kyushu University

Zitieren

APA

Zakaria, M. F., Kato, H., Sonoda, S., Kato, K., Uehara, N., Kyumoto-Nakamura, Y., Sharifa, M. M., Yu, L., Dai, L., Yamaza, H., Kajioka, S., Nishimura, F., & Yamaza, T. (2024). NaV1.1 contributes to the cell cycle of human mesenchymal stem cells by regulating AKT and CDK2. Journal of Cell Science, 137(19). https://doi.org/10.1242/jcs.261732

Vancouver

Zakaria MF, Kato H, Sonoda S, Kato K, Uehara N, Kyumoto-Nakamura Y, et al. NaV1.1 contributes to the cell cycle of human mesenchymal stem cells by regulating AKT and CDK2. Journal of Cell Science. 2024;137(19). doi:10.1242/jcs.261732

BibTeX
@article{Zakaria2024,
  author = {Zakaria, Mohammed Fouad and Kato, Hiroki and Sonoda, Soichiro and Kato, Kenichi and Uehara, Norihisa and Kyumoto-Nakamura, Yukari and Sharifa, Mohammed Majd and Yu, Liting and Dai, Lisha and Yamaza, Haruyoshi and Kajioka, Shunichi and Nishimura, Fusanori and Yamaza, Takayoshi},
  title = {NaV1.1 contributes to the cell cycle of human mesenchymal stem cells by regulating AKT and CDK2},
  journal = {Journal of Cell Science},
  year = {2024},
  volume = {137},
  number = {19},
  doi = {10.1242/jcs.261732}
}
Kostenlos starten →